Literature DB >> 9369286

Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations.

P Palatini1, E Casiglia, P Pauletto, J Staessen, N Kaciroti, S Julius.   

Abstract

Faster resting heart rate has been shown to be associated with a higher risk of developing hypertension and a greater incidence of cardiovascular morbidity and mortality. The aim of this study was to investigate the distribution of heart rate and its relationship with blood pressure and other cardiovascular risk factors in three populations. One European general population (Belgian study), one North American general population (Tecumseh study), and one European hypertensive population (HARVEST trial) were studied. Within each population, mixture analysis was used to investigate whether a mixture of two normal distributions explained the variance in heart rate better than a single distribution. In the men of all populations, mixture analysis identified a larger subpopulation of subjects with normal heart rate and a smaller one with fast heart rate. The subgroups with tachycardia had higher blood pressure and lipid levels than those with normal heart rate. In the populations in which they were measured, fasting insulin and postload glucose were also higher in the men with faster heart rate. A subgroup with tachycardia could also be singled out among the women from Tecumseh, but no relation between heart rate and blood pressure could be found. These findings show that in Western societies, high heart rate pertains to a distinct subgroup of subjects, who are more frequently men and exhibit the characteristic features of the insulin resistance syndrome. Sympathetic overactivity is likely to be the mechanism underlying this clinical condition.

Entities:  

Mesh:

Year:  1997        PMID: 9369286     DOI: 10.1161/01.hyp.30.5.1267

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  32 in total

Review 1.  Relevance of heart rate as a risk factor in hypertension.

Authors:  P Palatini; S Julius
Journal:  Curr Hypertens Rep       Date:  1999-06       Impact factor: 5.369

Review 2.  Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: rationale and options.

Authors:  Guido Grassi
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

3.  Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise.

Authors:  Robinson Joannides; Nicholas Moore; Michaela Iacob; Patricia Compagnon; Guy Lerebours; Jean-François Menard; Christian Thuillez
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

Review 4.  The role of cardiac autonomic function in hypertension and cardiovascular disease.

Authors:  Paolo Palatini; Stevo Julius
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

Review 5.  Heart rate and the cardiometabolic risk.

Authors:  Paolo Palatini
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

6.  Differentials and Determinants of Syndrome 'X' and its Role as Coronary Risk among Healthy Middle Aged Indian Army Personnel.

Authors:  Rajvir Bhalwar; V C Ohri; B L Somani; A S Kasthuri
Journal:  Med J Armed Forces India       Date:  2011-07-21

7.  Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort.

Authors:  Taku Inoue; Kunitoshi Iseki; Chiho Iseki; Yusuke Ohya; Kozen Kinjo; Shuichi Takishita
Journal:  Clin Exp Nephrol       Date:  2009-05-15       Impact factor: 2.801

8.  Metabolic syndrome is associated with delayed heart rate recovery after exercise.

Authors:  Jidong Sung; Yoon-Ho Choi; Jeong Bae Park
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

9.  Protective role of resting heart rate on all-cause and cardiovascular disease mortality.

Authors:  Arpit Saxena; Dawn Minton; Duck-chul Lee; Xuemei Sui; Raja Fayad; Carl J Lavie; Steven N Blair
Journal:  Mayo Clin Proc       Date:  2013-12       Impact factor: 7.616

10.  Heart rate and cardiovascular disease: an alternative to Beta blockers.

Authors:  Michael Liang; Aniket Puri; Gerard Devlin
Journal:  Cardiol Res Pract       Date:  2009-07-30       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.